Status epilepticus (SE) is a serious health issue in developing countries, with high morbidity and mortality rates of 3%-46%. There are two types of SE, convulsive status epilepticus (CSE) and non-convulsive status epilepticus. The most common type, CSE, is easy to detect but, in several cases, the patients are diagnosed too late to be properly treated and hospitalized. The present study therefore investigated the clinical manifestations of CSE in Indonesia. Patients with CSE treated at a tertiary hospital in Malang, Indonesia were observed retrospectively. Data on patients' clinical conditions and demographic characteristics were obtained from medical records. In total, 136 patients were diagnosed with CSE (male:female = 1.52:1), and almost one-third of this group were > 50 years of age (30%). Most patients (80.1%) suffered from general tonic-clonic seizures with an onset > 6 h after arrival at the hospital emergency room (63.2%). The most common etiology was withdrawal from an anti-seizure (antiepileptic) drug (31.6%), followed by stroke (24.3%). Patients were treated with diazepam (58.1%), phenytoin (89.7%), and anesthetic drugs (11.8%), 61.8% of the patients overcame seizures. The fatality rate was 19.9%, with the most common causes of death being brain herniation (37.0%), septic shock (29.6%), and respiratory failure (11.1%).
Introduction
Status epilepticus (SE) is a serious health issue in developing countries, with high morbidity and mortality rates of 3%-46% [1, 2] . Prolonged seizures (≥ 30 min) can trigger the initiation or failure of the seizure termination mechanism. Furthermore, depending on the type and duration of the seizures, long-term consequences, such as cell death, including neuronal cell death, neuronal injury, and neuronal network alterations, can result. SE is defined as either continuous seizures lasting ≥ 30 min or intermittent seizures in which consciousness is not regained between seizures [5] .
There are two types of SE, convulsive (CSE) and non-convulsive status epilepticus (NCSE). SE is classified as CSE if there are muscle contractions accompanying the seizure [3, 6] . The etiology of SE varies depending on age. SE in children usually develops because of fever or earlier infections. In adults, the majority of SE cases are caused by focal lesions in the brain, usually because of acute stroke. The other symptomatic causes involve metabolic disorders, hypoxia, and low levels of anti-epileptic medications [7] .
Moreover, the fatality rate of SE worldwide varies from 7% to 39% and is highly dependent on age, seizure duration, management, complications, and SE etiology [8, 9] . For example, SE is often undiagnosed despite the possibility that it is life-threatening. Therefore, this study aimed to investigate the clinical manifestations of CSE in Indonesia to improve its management and prognosis.
Materials and Methods
This was a descriptive, observational, retrospective study of the medical records of adult patients (≥ 14 years of age) with convulsive SE admitted to a tertiary hospital in Malang, Indonesia from January 1, 2011 to December 31, 2015 . The medical records were searched manually using the following keywords: "status epilepticus," "convulsive status epilepticus," "epilepsy," or "seizure." The diagnosis of CSE was based on the International League Against Epilepsy practical criteria diagnosis of CSE, which involve continuous convulsive seizures lasting ≥ 30 min or intermittent seizures with continuous unconsciousness between seizures [3] .
Confidentiality was ensured by giving a code number to each patient. The exclusion criteria in this study were < 14 years of age or insufficient data to confirm a diagnosis of CSE. The case descriptions involved only the latest episode of recurrent CSE. After confirming CSE, the following information was recorded: age, sex, CSE duration, type of seizure, history of epilepsy, oral treatment with anti-seizure drugs, CSE
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causes, brain imaging data, electroencephalography (EEG) results, treatment for CSE, and clinical outcomes.
Data regarding epilepsy and anti-seizure drug usage were obtained from patients' medical records. The duration of CSE was measured from the time of the first seizure noted in the records until its termination.
Data on the CSE durations were obtained from interviews with family members of patients or from physicians at the hospital.
CSE management at the hospital was based on the SE management guidelines issued by the Indonesia Neurology Association, with some modifications because of limitations on the availability of drugs.
There were three main types of drug treatment for patients: diazepam, phenytoin, and midazolam. Several patients were treated with common drugs, such as levetiracetam and valproic acid, during epilepticus therapy. Diazepam was used as the first-line therapy to immediately stop seizures after patients arrived at the hospital. If the patient still had seizures, the patient was treated using another anti-seizure drug.
Meanwhile, to prevent convulsions, phenytoin was given to all patients who had symptoms of permanent epilepticus.
Patients who developed refractory SE required anesthetic drugs. The anesthetic drug used in the hospital was midazolam injection. Midazolam was given as a bolus dosage of 0.1-0.2 mg/kg body weight (BW) and was continued with 0.05-0.5 mg/kg BW/h, titrated until the seizure stopped.
Results
The clinical characteristics of 136 CSE patients were analyzed (Table 1) . There were 68 patients who had the general seizure type. The average age of patients with CSE was 40.28 ± 17.56 years, with 30% of the patients > 50 years of age. CSE was found more frequently in males than in females (1.52:1). Most patients (63%) were hospitalized after > 6 h from the onset of seizures. Brain imaging was performed in 50% of patients with abnormal indications. Specifically, 93% of the patients had brain imaging.
Most patients (68%) had EEG recordings, and abnormal results were present in 70% of the EEG-recorded patients. Most abnormalities were detected in patients with a slow activity background (2 patients with a background frequency of 6-8 Hz and 17 patients with a background frequency < 6 Hz) with epileptogenic discharges of 74% from abnormal EEG results. Asymmetry patterns were found in two patients with posttrauma epilepsy (Table 2) .
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[ When the EEG examination results were compared according to the etiology of SE, normal EEG was usually found in cases of idiopathic epilepsy with antiepileptic drug (AED) withdrawal (41%), background abnormalities were most common in cases of septic encephalopathy (100%), and epileptogenic discharge was most common in stroke cases (72%). Additionally, EEG results showing the presence of brain abnormalities (i.e., asymmetry patterns) were found in head trauma cases (Table 4 ).
In total, 44% of patients had a history of epilepsy, and most of these patients were unemployed (58%).
However, these patients could receive treatment because they were insured by the national insurance system of the Indonesian government.
Etiology of CSE
Based on data regarding the 136 patients analyzed in this study, the most frequent etiology of CSE was anti-seizure drug withdrawal (44 patients), followed by stroke (33 patients), CNS infections (26 patients), post-trauma (12 patients), and CNS tumors (6 patients). Fifteen cases were caused by metabolic disorders, such as hyperglycemia (seven patients), uremic encephalopathy (five patients), and septic encephalopathy (three patients) ( Table 3) .
Management of CSE
SE progressed through three stages: early SE (seizure durations 5-30 min), permanent SE (seizure durations ≥ 30 min), and refractory SE (seizures persisting after receiving adequate doses of 2-3 types of early anti-convulsant medication). In the early stage of SE, it was essential to stabilize the airway, breathing, and circulation. Additionally, the seizures experienced by the patients were confirmed as true seizures and not as pseudo-seizures.
Seventy-nine patients were treated with diazepam to stop the seizures immediately after they arrived at the hospital. One ampule (10 mg) of diazepam was diluted with water to 10 mL for injection using a 10-mL syringe. This solution was slowly injected until the seizure stopped (0.1-0.2 mg/kg BW); the maximum dose was 30 mg. Thirty-two patients had a good response after diazepam treatment, which indicated that diazepam could stop the seizures. However, the other 47 patients still had seizures after diazepam injections (Fig. 2) .
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Phenytoin was administered to 122 patients. Phenytoin was injected as a second-line therapy for patients who still had seizures after diazepam injection or as a first-line therapy for permanent SE patients.
Phenytoin sodium was dissolved in 50 mL of 0.9% NaCl using a syringe pump. Phenytoin was slowly injected with a dose of 15-18 mg/kg BW, with a maximum rate of 50 mg/min. Unlike diazepam injection, phenytoin injection could not immediately stop seizures. Phenytoin was injected to prevent any seizure possibility. Of a total of 122 patients who were treated with phenytoin, 98 showed a positive response, demonstrating that phenytoin injections could prevent another seizure, especially in patients who had structural lesions in the central nervous system, thus requiring additional therapy for refractory SE.
However, 24 patients responded negatively to this treatment (Fig. 3 ).
Sixteen patients were treated with anesthetic drugs, which indicated that they had refractory SE.
Moreover, 12 patients showed a positive response, indicating that they could survive the seizures.
However, four patients did not respond to anesthetic drugs and died ( 
Clinical Outcomes of CSE
During the present study, 27 patients died, whereas 95 patients remained alive and were discharged with controlled seizures. Additionally, the status of 14 patients was not identified. These patients could not be identified because they were discharged at their request (before controlled seizures). Controlled seizures in the 50 surviving patients occurred after less than 7 days, whereas controlled seizures in the other patients occurred after more than 7 days. The most common cause of death was cerebral herniation (as evidenced by pathological lesions on brain imaging). The other causes were septic shock, respiratory failure, and hypoxic encephalopathy (Table 5 ).
Discussion
This study showed that the average age of patients with CSE in Indonesia was older than the average age of CSE patients in Africa but younger than the average age of patients in Europe, where the average was 60-75 years [10, 11, 12] . The predominance of men with CSE in our study is consistent with other studies
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[ [8, 11, 10, 12] . The causes of CSE were classified into symptomatic or unknown (cryptogenic) causes.
Cryptogenic SE was defined as SE with an unknown seizure etiology. The clinical outcome was recorded as either alive or dead. Furthermore, the causes of death were classified as the underlying disease, SE and its complications, or unknown.
Most cases of CSE in this study were of the general tonic-clonic seizure type, with CSE occurring more than 6 h after arrival at the hospital, which showed a delay in recognition and treatment. A tonic-clonic seizure is defined as a convulsion with clinical manifestations of contraction on both extremities, accompanied by a decrease of consciousness. The CSE duration was much longer than that reported by studies in the United States or Europe [9, 11, 13] . Possible reasons for the delay in treatment included cost, lack of public education about the importance of seizure management, and administrative issues in health facility referrals.
Anti-seizure drug withdrawal was the most common etiology of CSE in this study, which reflected a low level of compliance with regimens of anti-seizure drugs by patients with a history of epilepsy. Stroke was also a common etiology of CSE in this study, even though, compared with data from other developed countries, the contribution of cerebrovascular disease was lower [9, 13] .
There were two important parameters that were assessed in evaluating the results of the EEG: whether there was background rhythm abnormality and whether there were epileptiform discharges with potential as the epileptogenic focus. Normal brain activity has certain brain wave frequencies, and the normal value is strongly influenced by a person's age. Infants < 1 year of age have a normal brain wave frequency of less than 5 Hz; however, during brain maturation, individuals aged > 8 years have a brain wave frequency > 8 Hz under normal circumstances. The frequency of the brain wave is physiologically reduced in drowsiness. However, a slowdown in the conscious condition is a symptom of a brain disorder [9, 20, 31] .
The cortical or subcortical mechanisms involved in the generation of the background rhythm is disturbed, leading to synchronization of the background rhythm of abnormally slow frequencies. Abnormal background rhythm indicates that patients with SE might suffer from encephalopathy complications, partly due to the presence of brain hypoxia resulting from seizures or due to underlying diseases of the brain [19, 20] . In the present study, we found that abnormal background rhythm was found primarily in encephalopathy cases, especially septic encephalopathy. This was consistent with studies by Gloor et al.
(1986), Markand (1984) , and Schaul (1990) , who reported that cerebral perfusion and metabolic and toxic disorders were major causes of slow activity in adults [32, 33, 34] .
Epileptiform discharges were found in only 74% of patients with abnormal EEG results, which was much lower than in a previous study [20, 21] . This difference could have been caused by the limitations of the ACCEPTED MANUSCRIPT
facilities, which could perform only routine EEGs and not continuous EEG monitoring. Epileptiform discharges are waves formed by a large difference in polarity in brain cell activity; these can be used as a marker of epileptogenic focus [31] . In the present study, epileptiform discharges were usually found in stroke cases (68%), although this result was still lower than that in other studies [21, 22] . The occurrence of seizures in stroke patients could have been caused by an ischemic stroke if the release of glutamate from terminal axons disrupted the thalamocortical circuit. Initial seizure incidence is more common in cortical stroke. Large infarcts in the supramarginal gyrus and the superior temporal gyrus are risk factors for further seizures. Although initial seizures do not always involve epilepsy, they can lead to epileptogenesis, which increases the risk of epilepsy [35, 36] . In bleeding strokes, the mechanism of ectogenesis involves iron deposition due to decomposition of blood products from the hematoma. Iron deposition can inhibit several functions, including glutamate retrieval and glutamate synthetase functions [36] .
In addition to background abnormalities and epileptiform discharges, there are some special patterns, including asymmetry patterns, that can be evaluated using EEG. Asymmetry refers exclusively to amplitude differences in physiological EEG activity. Asymmetry is defined when a hemisphere with lower amplitude shows a reduction of at least 50% compared with the homotopic contralateral region, or when there is an amplitude increase of at least 50%. Asymmetries are reliable signs of regional structural lesions. Amplitude reduction can be seen in ischemic lesions, whereas elevated amplitude can be seen in chronic lesions with scar formation (32, 37) . In the present study, asymmetric patterns were also found in two patients with post-trauma SE, indicating that there were extensive brain damage lesions in these patients; this conclusion was supported by the imaging examinations showing massive post-trauma brain hemorrhages. This finding was similar to the results of a study by Daly and Markand (1990) , who reported that asymmetries were frequently seen in patients with brain traumas [37] .
We also found normal EEGs in 30% of patients with CSE, with most being found in cases of idiopathic epilepsy with AED withdrawal (41%). This normal EEG percentage was higher than those in other studies. While normal EEG in the case of SE status did not involve 20% of the cases [12, 20] . However, in the present study, EEG examinations could be performed on only 68% of patients, with only 30 min. of interictal examination. This may be one of the reasons for not detecting EEG abnormalities in cases of CSE. EEG abnormalities in cases of idiopathic epilepsy are strongly affected by age and type of epilepsy syndrome. For example, in Gran Mal epileptic syndrome, namely, general tonic-clonic epilepsy syndrome, interictal abnormalities are very rare and are found in less than 8% of patients [32] .
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[ Based on the consensus regarding the treatment of SE, 79 patients were treated with diazepam, whereas the rest were not treated with this drug as they had already received diazepam therapy before admission to the hospital (by a hospital referral or public health services) or because the seizures had already stopped.
According to the SE management protocol issued by the Indonesia Neurology Association, the initial and subsequent treatment approaches for stopping seizures when the patient arrives at the hospital involve intravenous lorazepam. However, it was difficult to receive injected lorazepam intravenously at the hospital in this study. There was also no difference in the treatment-emergent adverse event profiles between lorazepam and diazepam in three adult class I and class II SE studies (26, 27, 28) . In the present study, diazepam injection was effective in stopping seizures in 40% of CSE cases, and it was especially effective with the etiology phenytoin is an acceptable alternative (level B) [29] . Based on these data, phenytoin injection was chosen as the second-line therapy for permanent SE patients, because phenytoin injection was considered to be easier to obtain and cheaper than other drugs. It was found that phenytoin was effective in controlling seizures in 80% of CSE cases, whereas the other 20% of cases developed into refractory SE, especially when severe brain abnormalities were involved. Phenytoin is the most common second-line therapy used to treat SE, with an efficacy ranging from 54% to 80% [8, 10, 12, 20] . Efficacy depends on multiple factors, including the etiology of the SE [17, 18] .
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There are three types of anesthetic drugs that can be used to control seizures: midazolam, propofol, and sodium thiopental. Midazolam was chosen as the treatment for refractory SE because it has lower rates of complications involving respiratory failure [17, 18] refractory SE in this study because it had less efficacy than it did in the other studies, which may have been caused by the longer duration of SE, multiple comorbidities, and/or extensive brain damage [17, 18, 20] The therapeutic response to the seizure medications administered in this study was determined based only on clinical observation (i.e., whether the seizure was terminated). When > 10% of patients were treated for SE, clinical seizures were stopped because they showed only subtle symptoms even when the electrographic seizures continued. This condition is known as subtle CSE.
Furthermore, this is included as part of the NCSE type that is used to describe the late "burned-out" stage of SE, when both the motor and EEG expressions of seizures become less florid (24) . This stage is similar to the stuporous stage described by Clark and Prout [25] . NCSE can be diagnosed only by a continuous EEG examination. Continuous EEG was not performed due to the lack of proper equipment. Therefore, it could not be confirmed whether NCSE occurred [21, 22] .
NCSE following CSE can be caused by inadequate SE therapy. Anti-seizure drugs usually affect ion channels (i.e., by inhibiting sodium or calcium channels). By regulating ion channels, the anti-seizure drug alters muscular contractions and inhibits abnormal brain electric discharge activities that result in seizures. When anti-seizure drug levels are inadequate, muscular contraction is inhibited, but electrical discharges in the brain cannot be completely stopped. As a result, motor activity is not detected, but abnormal EEG remains [4, 5, 19, 23] .
According to the number of patients who had pathological lesions on brain imaging, the fatality rate in CSE patients in this study was quite high, reaching 19.9%. The most common cause of death was cerebral herniation. The other causes of death were septic shock, respiratory failure, and encephalopathy. The higher fatality rate in this study may have resulted from the longer duration of CSE.
This study's ability to address cause-effect relationships may have been limited by the retrospective method used for the analyses. Another limitation of this study was that observations focused only on patients with CSE, which was easier to diagnose than NCSE; however, EEG was required to identify these types of cases. Furthermore, the 24-h EEG examination was not used because there were no ACCEPTED MANUSCRIPT
[ facilities that could differentiate CSE from NCSE. The determination that CSE was caused by anti-seizure drug withdrawal was based on only medical history and not on anti-seizure drug levels.
Conclusion
Based on the results of this study, anti-seizure drug withdrawal was the most common etiology of CSE in Indonesia. The fatality rate was still high, with the most common cause of death involving cerebral herniation. Moreover, some of the SE management guidelines issued by the Indonesian Neurology Association could not be implemented due to drug limitations, such as the unavailability of lorazepam injections, which were replaced by diazepam injections, and of intravenous fosphenytoin injections, which were replaced by phenytoin injections. However, these drug substitutions were found to be sufficiently effective for treating SE, especially SE cases without organic brain lesions. Therefore, the study results provide alternative SE management strategies for areas with limited drug availability.
However, further studies are required for better management of SE.
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[ Tables   Table 1. Clinical characteristics of convulsive status epilepticus patients.
Age ( 
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